RE:RE:RE:It takes $200 Million plus for a Phase III approval
Jeff.....the 70 million you keep tossing around (if that amount is even accurate) would be the final amount needed as you say under orphan drug status. You are talking about several years before phase 3 is complete. Which gives plenty of time to secure funding via many means, ample time for share price to increase as well (helping to secure funding more so), company gets bought out (negating need for funding) and don't forget the companies plans for roll out of cannabis dispensary across the EU under pharmadrug and the shroom business expansion expanding under Slim Winkel in the Netherlands and I believe the EU as well....which will all contribute to bottom line and increasing share value. With all that said I struggle to see your point with the urgency to come up with this quoted 70 million at your fever pitch. Read up before you bash eh....